Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
293 participants
INTERVENTIONAL
2026-04-30
2027-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Trials Outreach & Education
NCT05064423
OPEN & ASK: Improving Patient-Centered Communication in Primary Care
NCT03385512
Assessment of Comskil Training Through Videorecording and Patient Surveys
NCT00943813
Drug Facts Page or a Short Drug Summary in Helping Patients and Doctors Understand Medical Information
NCT00450931
Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer
NCT00769431
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ask Questions about Clinical Trials (ASQ-CT) Brochure
Ask Questions about Clinical Trials (ASQ-CT), a clinical trial communication intervention brochure
Ask Questions about Clinical Trials brochure
Communication intervention called a question prompt list
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ask Questions about Clinical Trials brochure
Communication intervention called a question prompt list
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Appointment to see a provider at a Karmanos Cancer Institute-McLaren or a medical encounter at McLaren Center for Research and Innovation (MCRI) site for medical/systemic treatment
* Potentially eligible for a clinical trial
* Speak and read English well enough to be able to understand consent documents and complete surveys
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barbara Ann Karmanos Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lauren Hamel
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lauren M Hamel, PhD, MBA
Role: PRINCIPAL_INVESTIGATOR
Wayne State University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-082
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.